For informational purposes only — not investment advice

← Back to signals

SSP

E.W. SCRIPPS Co

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
6.3d↓-10.8%
as of 2026-09-30

News Summary

Negative

SSP reported Q2 2026 revenue of $490M (down from $517M in Q1) with a $1.2B shareholder loss driven by a $11.61/share non-cash goodwill impairment charge, signaling significant asset write-downs. While management implemented cost controls and guided to $225–250M in local political revenue for 2026, the analyst consensus downgraded the price target from $4.70 to $3.80, and consensus rating remains 'Hold,' reflecting investor skepticism about the turnaround.

Red flags

  • •Goodwill impairment charge of $11.61 per share in Q2 indicates material overvaluation of prior acquisitions
  • •Sequential revenue decline Q1 to Q2 ($517M to $490M)
  • •Net leverage at 3.9x at Q1 end suggests elevated debt relative to earnings capacity
  • •Wells Fargo price target cut 19% (from $4.70 to $3.80) on Aug. 11, 2026
  • •Analyst consensus 'Hold' rating with no price upside implied
  • •Ongoing organizational restructuring and leadership changes suggest operational challenges

Fund 13D/13G Filings (1)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Point72SC 13GNEW5.2%
-1.8% vs SPY
-2.6% abs
2026-10-05↗